跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUBIFEN PROLONG 30 MG CAPSULA DURA DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RUBIFEN PROLONG 30 MG CAPSULA DURA DE LIBERACION MODIFICADA EFG
Approved
STANDARD
RUBIFEN PROLONG 30 MG CAPSULA DURA DE LIBERACION MODIFICADA EFG
Laboratorios Rubio S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2023
Approval ID
63c4049ad1b566ab
Company
Laboratorios Rubio S.A.
Type
Standard
Approval Details
Approval Id
63c4049ad1b566ab
Drug Cima Aemps Name
RUBIFEN PROLONG 30 MG CAPSULA DURA DE LIBERACION MODIFICADA EFG
Register Number
88837
Holder Company Name
Laboratorios Rubio S.A.
Marketing Company Name
Laboratorios Rubio S.A.
Authorization Date
2023-05-09
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized
Yes
Company Name
Laboratorios Rubio S.A.
Active Ingredients
METILFENIDATO HIDROCLORURO
30 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2023
Approval ID
63c4049ad1b566ab
Type
Standard
Back to CIMA-AEMPS Approvals